ACUTE MYELOGENOUS LEUKEMIA
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Leukemia vaccine aims to stop relapse after chemo
⭐️ VACCINE ⭐️ OngoingThis study tests a custom-made vaccine for adults aged 55 and older with acute myeloid leukemia (AML) who are in remission after chemotherapy. The vaccine is made from the patient's own leukemia cells fused with immune-boosting cells, designed to train the body to fight any remai…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:02 UTC
-
New stem cell transplant approach offers hope for blood cancer patients
Disease control OngoingThis study tests a stem cell transplant using donors who are not a perfect match for patients with blood cancers like leukemia and lymphoma. Doctors give special drugs after the transplant to lower the risk of graft-versus-host disease, a common complication. The goal is to see i…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
New pill shows promise for tough blood cancers
Disease control TerminatedThis study tests an oral drug called emavusertib (CA-4948) in adults with acute myeloid leukemia (AML) or a high-risk bone marrow disorder (MDS). The goal is to find the best dose and see if it can shrink or control the cancer. Participants must have already tried at least one st…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New vaccine aims to keep leukemia in check after transplant
Disease control OngoingThis early-phase study tests a custom-made cancer vaccine (DC/AML fusion) for people with acute myeloid leukemia who have recently had a stem cell transplant. The vaccine is designed to train the immune system to recognize and attack remaining leukemia cells. Some participants al…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Scientists seek blood cancer samples to unlock new treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from 550 people with blood cancers like leukemia and lymphoma. Researchers will study the samples in the lab to learn more about how these cancers work and find new ways to treat them. Participants give samples during their regula…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:13 UTC